DACIA ENGBERG: Open Payments
NPI 1528221769 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 12 payments from 11 companies in 2025. Trend: 2023 $228 · 2024 $181 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $60 |
| Astellas Pharma US Inc | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Philips North America LLC | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Intracept, Veozah, QULIPTA, Ambulatory Monitoring & Diagnostics Undivided, General - Pain Management, REZDIFFRA, NUCALA, NURTEC ODT.
Industry payments across ND — which companies pay providers there.
